LeMaitre Vascular, Inc. (LMAT) Earnings History
Annual and quarterly earnings data from 2004 to 2025
Loading earnings history...
LMAT EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
LMAT Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 71.5% | 27.2% | 23.1% |
| 2024 | 68.6% | 23.8% | 20.0% |
| 2023 | 65.7% | 19.0% | 15.6% |
| 2022 | 64.9% | 16.6% | 12.8% |
| 2021 | 65.7% | 23.6% | 17.4% |
Download Data
Export LMAT earnings history in CSV or JSON format
Free sign-in required to download data
LeMaitre Vascular, Inc. (LMAT) Earnings Overview
As of May 8, 2026, LeMaitre Vascular, Inc. (LMAT) reported trailing twelve-month net income of $62M, reflecting +30.6% year-over-year growth. The company earned $2.71 per diluted share over the past four quarters, with a net profit margin of 23.1%.
Looking at the long-term picture, LMAT's 5-year EPS compound annual growth rate (CAGR) stands at +19.4%, indicating exceptional earnings growth. The company achieved its highest annual net income of $58M in fiscal 2025, representing a new all-time high.
LeMaitre Vascular, Inc. maintains industry-leading profitability with a gross margin of 71.5%, operating margin of 27.2%, and net margin of 23.1%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including ATRC (-$5M net income, -2.1% margin), NVCR (-$173M net income, -20.8% margin), ANGO (-$28M net income, -11.6% margin), LMAT has outperformed on profitability metrics. Compare LMAT vs ATRC →
LMAT Earnings vs Peers
Earnings metrics vs comparable public companies
LMAT Historical Earnings Data (2004–2025)
22 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $58M | +31.1% | $68M | $2.52 | 23.1% | 27.2% |
| 2024 | $44M | +46.3% | $52M | $1.93 | 20.0% | 23.8% |
| 2023 | $30M | +45.9% | $37M | $1.34 | 15.6% | 19.0% |
| 2022 | $21M | -23.3% | $27M | $0.93 | 12.8% | 16.6% |
| 2021 | $27M | +26.8% | $36M | $1.25 | 17.4% | 23.6% |
| 2020 | $21M | +18.3% | $29M | $1.04 | 16.4% | 22.3% |
| 2019 | $18M | -21.8% | $21M | $0.88 | 15.3% | 18.1% |
| 2018 | $23M | +33.6% | $28M | $1.13 | 21.7% | 26.7% |
| 2017 | $17M | +62.2% | $21M | $0.86 | 17.0% | 20.9% |
| 2016 | $11M | +36.5% | $16M | $0.55 | 11.9% | 18.3% |
See LMAT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LMAT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LMAT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLMAT — Frequently Asked Questions
Quick answers to the most common questions about buying LMAT stock.
Is LMAT growing earnings?
LMAT EPS is $2.71, with earnings growth accelerating to +30.6%. This exceeds the 5-year CAGR of +19.4%. TTM net income reached $62M.
What are LMAT's profit margins?
LeMaitre Vascular, Inc. net margin is +23.1%, with operating margin at +27.2%. Above-average margins indicate pricing power.
How consistent are LMAT's earnings?
LMAT earnings data spans 2004-2025. The accelerating earnings trend is +30.6% YoY. Historical data enables comparison across business cycles.